Business News • MarketWire • Vicor Technologies' Chief Medical Officer to Present Abstract on Hypovolemia Study Results at the AABB 2010 Annual Meeting |
Vicor Technologies' Chief Medical Officer to Present Abstract on Hypovolemia Study Results at the AABB 2010 Annual Meeting |
|
|
Vicor Technologies' Chief Medical Officer to Present Abstract on Hypovolemia Study Results at the AABB 2010 Annual Meeting
BOCA RATON, FL--(Marketwire - July 28, 2010) - David H. Fater, CEO of Vicor Technologies, Inc. (OTCBB: VCRT), today announced that Vicor Chief Medical Officer Dr. Daniel Weiss will present an abstract of the results of a pilot study to test the ability of Vicor's PD2iŽ nonlinear algorithm to detect acute hypovolemia at the AABB 2010 Annual Meeting. Vicor Technologies is a biotechnology company focused on the development of innovative, non-invasive medical devices using its patented, proprietary PD2iŽ nonlinear algorithm and software. Vicor is currently in the process of commercializing diagnostics that accurately risk stratify specific target populations for future pathological events including cardiac death resulting from arrhythmia or pump failure, and autonomic nervous system dysfunction, and trauma victims in need of lifesaving intervention.
View More : http://www.marketwire.com/mw/release.do?id=1296614&sourceType=3
|
|
|